ETFMG U.S. Alternative Harvest ETF company info

What does ETFMG U.S. Alternative Harvest ETF do?
ETFMG U.S. Alternative Harvest ETF (NYSE:MJ) focuses on the cannabis industry, aiming to provide investment results that closely correspond to the total return performance of the Prime Alternative Harvest Index. This index measures the performance of companies within the cannabis ecosystem bene?tting from global medicinal and recreational cannabis legalization initiatives. The ETF offers exposure to a range of cannabis-related businesses, including biotechnology companies developing cannabis-based pharmaceuticals, companies that produce, market, or distribute cannabis products, and ancillary businesses related to the industry. MJ's objective is to tap into the growth potential of legal cannabis, adapting to evolving legal and regulatory environments to offer investors a diversified portfolio within this emerging sector.
ETFMG U.S. Alternative Harvest ETF company media
Company Snapshot

Is ETFMG U.S. Alternative Harvest ETF a public or private company?

key
Ownership
Public

How many people does ETFMG U.S. Alternative Harvest ETF employ?

people
Employees
22

What sector is ETFMG U.S. Alternative Harvest ETF in?

pie chart
Sector
ETF

Where is the head office for ETFMG U.S. Alternative Harvest ETF?

location pin
Head Office
Illinois, United States

What year was ETFMG U.S. Alternative Harvest ETF founded?

founded flag
Year Founded
2021
What does ETFMG U.S. Alternative Harvest ETF specialise in?
/Cannabis investments /ETF Management /Portfolio Diversification /Risk Management /Asset Allocation /Investment Advisory

What are the products and/or services of ETFMG U.S. Alternative Harvest ETF?

Overview of ETFMG U.S. Alternative Harvest ETF offerings
Invests in global cannabis companies, primarily in the U.S.
Targets companies involved in the legal production, growth, and distribution of cannabis.
Focuses on the burgeoning medical and recreational marijuana sectors.
Includes holdings in biotech firms focused on cannabinoid-based pharmaceuticals.
Features investments in ancillary businesses related to the cannabis industry.
Engages in cannabis industry advocacy and legal reform support through strategic investments.